Similarly, another key sign of AD is brain glucose hypometabolism which is believed to produce mitochondrial deficits which have been shown to lead to altered APP processing and increase amyloid-beta and tau phosphorylation (Mosconi, 2005; Dewanjee et al., 2022). This evidence concerns the gene MAPT and Alzheimer disease.